MedCity Update – October 2015
View this email in your browser


From Eliot Forster, MedCity’s Executive Chair


This slightly delayed newsletter comes to you following a packed visit to BioJapan by MedCity, where we were joined by some exciting SMEs, pre-eminent scientists, experts, business leaders and, not least, the Mayor of London, to highlight the region’s excellence in cell and regenerative medicine.

Jetlag notwithstanding, our visit was a huge success and, with the Mayor’s help, created a real buzz and high levels of interest in our region. Japan is the second largest investor in the life sciences sector in the greater south east, second only to the USA, so this was an invaluable opportunity to demonstrate our talent in the field of cell and regenerative medicine, an area that is a major priority for R&D and commercialisation within Japan. You can read all about our visit below.

On a different subject, we now have a new website, launched just in advance of our visit to Japan:  We are still in a period of development so your feedback would be extremely valuable – please tell us what you think at 

MedCity launches cell therapy campaign at BioJapan

MedCity has led a delegation of SMEs, scientists and industry to promote partnerships in cell therapy and regenerative medicine between Japan and the greater south east. The new campaign, developed with London & Partners and the GREAT Britain campaign, brings together figures including Life Sciences Minister George Freeman, UCL’s Professor Chris Mason, and the Cell Therapy Catapult’s Keith Thompson. 

Read more

See the report

Watch the campaign video

New Angels in MedCity events 

The next free Angels in MedCity investor workshop for people interested in finding out more about investing in life sciences takes place on Thursday 12 November at the home of Johson & Johnson Innovation in London.

Find out more and register 


Read more about Angels in MedCity

Mayor of London announces new UCL-Takeda partnership

Mayor of London Boris Johnson has announced a new partnership between University College London and Asia’s largest pharmaceutical company Takeda during last week’s trade mission to Japan. The Mayor also unveiled a new report from PwC’s Strategy& based on interviews with leading Japanese life sciences companies that reveals the strengths that attract them to the greater south east and identifies issues to be addressed. 

Read more

Read the full Strategy& report – tell us what you think

MedCity has launched its new website with new richer content to promote and support life sciences in the greater south east.

Please explore our new site and tell us what you think

London MedTech: Innovation and Investment Trends

MedCity, SEHTA and the GLA are bringing together the medtech community for a free event at City Hall on Thursday 3 December.

The event will include views from key players in the sector including Johnson & Johnson Innovation, GE Healthcare and Microsoft on future trends, areas of investment for corporate R&D, and ways to encourage collaboration. 

Read more and register

OneStart 2016 – open now

OneStart, the world’s largest life sciences and healthcare start-up accelerator programme, is now open to applications for it’s fourth year. 

Find out more and apply

Read more about 2015’s winning team

Genesis 2015

MedCity is a Gold Sponsor of Genesis 2015, which takes place on Thursday 10 December at the QEII Centre, London.

With an over-arching theme of Taking Bio-Innovation to the Global Market, the speakers and panellists will focus on key components for success. Confirmed speakers include senior executives from the global investment, pharma, healthcare and advisory sectors.

Read more and register

MedTechSouthEast – pitching event

Join MedCity and Design Council for the pitching event of MedTechSouthEast – a new accelerator programme for medtech entrepreneurs focusing on independent living. Hear from the final 15 applicants about their innovations on Tuesday 10 November in central London – registration from 6pm.

Invitation only – for more details and to register email Design Council’s Tracey Breeze

Read more about MedTechSouthEast

Building the global cluster – BIA/EY report

2014 was the best year to date for investment in the UK bioscience sector, according to a new report from the BIA and EY, with £1.2bn raised in innovation capital, up 143% on 2013. 

Find out more

London-east UK launches new post-incubation centre

Science park Londoneast-UK has announced that it is creating The Cube, a new post-incubation centre for emerging science R&D companies.

Find out more

Coming up


SVC2UK HealthTech Summit, SVC2UK, 5 November
Solving the innovation conundrum, ABPI, 11 November
LRMN and Cell Therapy Catapult, London Regenerative Medicine Network, 11 November
BioBeat15, BioBeats, 20 November
CEO & Investor Networking Forum, OBN, 24 November

Annual bioProcessUK Conference, BIA, 25 November

Email us to share your event

MedCity was established in April 2014 by the Mayor of London with the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCL Partners.

The next edition of MedCity Update will be sent in the first week of November


Copyright © 2015 MedCity. All rights reserved.